Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,024+, returning 9,630.5%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,630.54% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Diginex Limited Ordinary Shares (DGNX) | 2,435.21% |
ZimVie (ZIMV) | 1,531.21% |
Abivax SA American Depositary Shares (ABVX) | 1,293.65% |
DeFi Development (DFDV) | 1,115.63% |
Oncology Institute (TOI) | 906.54% |
Newegg Commerce (NEGG) | 879.75% |
Zepp Health (ZEPP) | 869.23% |
180 Life Sciences (ATNF) | 838.55% |
Abits (ABTS) | 809.09% |
FiEE (FIEE) | 734.86% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 725% |
Nova Lifestyle I (NVFY) | 713.92% |
Relmada Therapeutics (RLMD) | 647.88% |
Sandisk (SNDK) | 594.72% |
Palvella Therapeutics (PVLA) | 593.37% |
Nanobiotix (NBTX) | 551.77% |
Celcuity LLC (CELC) | 550.53% |
Better Home & Finance (BETR) | 527.09% |
Thayer Ventures Acquisition (TVACW) | 523.33% |
Global Interactive Technologies (GITS) | 522.41% |
Galecto (GLTO) | 482.43% |
Lizhi (SOGP) | 468.87% |
Dominari (DOMH) | 435.66% |
